Abstract
Cardiovascular diseases have their origin in childhood. Early biomarkers identifying individuals with increased risk for disease are needed to support early detection and to optimize prevention strategies. By applying machine learning approach on high throughput NMR-based metabolomics data, we identified metabolic predictors of cardiovascular risk in circulation in a cohort of 396 females, followed from childhood (mean age 11.2 years) to early adulthood (mean age 18.1 years). The identified childhood metabolic signature included three circulating biomarkers robustly associating with increased cardiovascular risk in early adulthood (AUC = 0.641 to 0.802, all p<0.01). These associations were confirmed in two validation cohorts including middle-aged women, with similar effect estimates. We subsequently applied random intercept cross-lagged panel model analysis, which suggested causal relationship between metabolites and cardio-metabolic risk score from childhood to early adulthood. These results provide evidence for the utility of circulating metabolomics panel to identify children and adolescents at risk for cardiovascular disease, to whom preventive measures and follow-up could be indicated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was financially supported by the Academy of Finland, Ministry of Education of Finland and University of Jyväskylä. The National Nature Science Foundation of China (Grant 31571219), the 111 Project (B17029), the Shanghai Jiao Tong University Zhiyuan Foundation (Grant CP2014013), and China Postdoc Scholarship Council (201806230001).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This study was financially supported by the Academy of Finland, Ministry of Education of Finland and University of Jyväskylä. The National Nature Science Foundation of China (Grant 31571219), the 111 Project from Ministry of Education of China (B17029), the Shanghai Jiao Tong University Zhiyuan Foundation (Grant CP2014013), and China Postdoc Scholarship Council (201806230001)
Data Availability
Data will available upon request
